United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Oct 8, 2026 · Filed Oct 9, 2026

On Oct 8, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$534.31 for US$5.08M under a trading plan, leaving 324,443 shares. Filed Oct 9, 2026 (Form 4).

Sold
9,500 shares
Price
US$534.31 average (US$525.50 to US$541.23)
Value
US$5.08M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 8, 2026Common StockOption exercise9,500US$117.76333,943Indirect
Oct 8, 2026Common StockSale200US$525.50333,743Indirect
Oct 8, 2026Common StockSale767US$526.66332,976Indirect
Oct 8, 2026Common StockSale273US$527.57332,703Indirect
Oct 8, 2026Common StockSale200US$528.63332,503Indirect
Oct 8, 2026Common StockSale199US$530.13332,304Indirect
Oct 8, 2026Common StockSale1,061US$531.07331,243Indirect
Oct 8, 2026Common StockSale600US$532.07330,643Indirect
Oct 8, 2026Common StockSale800US$533.36329,843Indirect
Oct 8, 2026Common StockSale920US$534.28328,923Indirect
Oct 8, 2026Common StockSale480US$535.46328,443Indirect
Oct 8, 2026Common StockSale824US$536.61327,619Indirect
Oct 8, 2026Common StockSale1,016US$537.53326,603Indirect
Oct 8, 2026Common StockSale605US$538.60325,998Indirect
Oct 8, 2026Common StockSale1,091US$539.58324,907Indirect
Oct 8, 2026Common StockSale424US$540.51324,483Indirect
Oct 8, 2026Common StockSale40US$541.23324,443Indirect

Source

View original at SEC

Related